VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Kubota Corporation vs Abbott Laboratories
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Kubota Corporation
6326 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Kubota Corporation's moat claims, evidence, and risks.
View 6326 analysisAbbott Laboratories
ABT · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.
View ABT analysisComparison highlights
- Moat score gap: Kubota Corporation leads (73 / 100 vs 64 / 100 for Abbott Laboratories).
- Segment focus: Kubota Corporation has 3 segments (87.4% in Farm & Industrial Machinery); Abbott Laboratories has 7 segments (26.7% in Cardiovascular & Electrophysiology Devices).
- Moat breadth: Kubota Corporation has 6 moat types across 3 domains; Abbott Laboratories has 10 across 3.
Primary market context
Kubota Corporation
Farm & Industrial Machinery
Agricultural machinery and compact construction equipment (incl. compact/utility tractors, construction machinery, engines)
Global
Dealers and end users (farmers, contractors, municipalities)
OEM
87.4%
Abbott Laboratories
Cardiovascular & Electrophysiology Devices
Cardiovascular, electrophysiology, rhythm management, structural heart and heart failure devices
Global
Hospitals, ambulatory surgery centers, cardiologists/electrophysiologists
Implantable device manufacturer
26.7%
Side-by-side metrics
Moat coverage
Shared moat types
Kubota Corporation strengths
Abbott Laboratories strengths
Segment mix
Kubota Corporation segments
Full profile >Farm & Industrial Machinery
Oligopoly
Water & Environment
Competitive
Other
Competitive
Abbott Laboratories segments
Full profile >Established Pharmaceutical Products
Competitive
Diagnostic Products
Oligopoly
Pediatric Nutrition
Oligopoly
Adult Nutrition
Oligopoly
Diabetes Care (CGM & glucose monitoring)
Duopoly
Cardiovascular & Electrophysiology Devices
Oligopoly
Neuromodulation Devices
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.